The new guidance includes updates on diabetes technology use, GLP-1 receptor agonists, liver disease, drinking water, and ...

Medicare Advantage plans are paid more for enrolling people who seem sicker, because these people typically use more care and so would be more expensive to cover in traditional Medicare. However, ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Washington — Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...

Expertise Smart home devices, outdoors gadgets, smartphones, wearables, kid's tech, and some dabbling in 3D printing Credentials Covered the mobile and smart home tech space for the past five ...

It may soon get easier for people who rely on Medicare and Medicaid to access blockbuster obesity drugs like Wegovy and Zepbound. The Biden administration is proposing a new rule to expand coverage.

According to the Centers for Medicare and Medicaid ... (NASDAQ:DXCM) is a medical device company that specializes in continuous glucose monitoring (CGM) systems for diabetes management.

The report that's being released is showing us that uh obesity in the US continues to affect uh almost half of the uh of the US population of adults. Uh It's particularly uh affecting people from ...

Although Medicare offers extensive coverage for hospital visits, surgeries, and outpatient care, dental services fall into a different category. Since Medicare provides coverage primarily for seniors, ...

Weight-loss drugs like Ozempic and Zepbound would be covered by Medicare and Medicaid, giving access to millions of Americans, under a new proposal from the Biden administration. "This proposal ...

Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk. Photo: James Manning/PA Images via Getty Images ...